Health Law & Business News

Battle Over Drug Prices in TV Ads Hinges on Lone Medical Study

July 8, 2019, 9:30 AM

A medical journal study is figuring prominently in a federal judge’s decision whether to delay a new requirement that drug companies include list prices in TV advertising.

Attorneys for Merck & Co., Eli Lilly and Co., and Amgen Inc. argued last week that the Department of Health and Human Services and the Centers for Medicare & Medicaid Services are violating their First Amendment rights; lack the statutory authority to impose such a requirement; and would only mislead the public about drug costs because few patients ever pay the wholesale, or “list,” price.

Judge Amit P. Mehta said he would...

To read the full article log in. To learn more about a subscription click here.